483 related articles for article (PubMed ID: 12610176)
1. Treatment of children with nonmetastatic paratesticular rhabdomyosarcoma: results of the Malignant Mesenchymal Tumors studies (MMT 84 and MMT 89) of the International Society of Pediatric Oncology.
Stewart RJ; Martelli H; Oberlin O; Rey A; Bouvet N; Spicer RD; Godzinski J; Stevens MC;
J Clin Oncol; 2003 Mar; 21(5):793-8. PubMed ID: 12610176
[TBL] [Abstract][Full Text] [Related]
2. Primary chemotherapy in rhabdomyosarcomas and other malignant mesenchymal tumors of the orbit: results of the International Society of Pediatric Oncology MMT 84 Study.
Rousseau P; Flamant F; Quintana E; Voute PA; Gentet JC
J Clin Oncol; 1994 Mar; 12(3):516-21. PubMed ID: 7509854
[TBL] [Abstract][Full Text] [Related]
3. Soft tissue sarcoma or malignant mesenchymal tumors in the first year of life: experience of the International Society of Pediatric Oncology (SIOP) Malignant Mesenchymal Tumor Committee.
Orbach D; Rey A; Oberlin O; Sanchez de Toledo J; Terrier-Lacombe MJ; van Unnik A; Quintana E; Stevens MC
J Clin Oncol; 2005 Jul; 23(19):4363-71. PubMed ID: 15994146
[TBL] [Abstract][Full Text] [Related]
4. Treatment of nonmetastatic rhabdomyosarcoma in childhood and adolescence: third study of the International Society of Paediatric Oncology--SIOP Malignant Mesenchymal Tumor 89.
Stevens MC; Rey A; Bouvet N; Ellershaw C; Flamant F; Habrand JL; Marsden HB; Martelli H; Sanchez de Toledo J; Spicer RD; Spooner D; Terrier-Lacombe MJ; van Unnik A; Oberlin O
J Clin Oncol; 2005 Apr; 23(12):2618-28. PubMed ID: 15728225
[TBL] [Abstract][Full Text] [Related]
5. Paratesticular rhabdomyosarcoma in children and adolescents-Outcome and patterns of relapse when utilizing a nonsurgical strategy for lymph node staging: Report from the International Society of Paediatric Oncology (SIOP) Malignant Mesenchymal Tumour 89 and 95 studies.
Rogers T; Minard-Colin V; Cozic N; Jenney M; Merks JHM; Gallego S; Devalck C; Gaze MN; Kelsey A; Oberlin O; Stevens M; Spicer RD; Bergeron C; Martelli H
Pediatr Blood Cancer; 2017 Sep; 64(9):. PubMed ID: 28205365
[TBL] [Abstract][Full Text] [Related]
6. Local therapy is critical in localised pelvic rhabdomyosarcoma: experience of the International Society of Pediatric Oncology Malignant Mesenchymal Tumor (SIOP-MMT) committee.
Réguerre Y; Martelli H; Rey A; Rogers T; Gaze M; Ben Arush MW; Devalck C; Oberlin O; Stevens M; Orbach D
Eur J Cancer; 2012 Sep; 48(13):2020-7. PubMed ID: 22154650
[TBL] [Abstract][Full Text] [Related]
7. Treatment of non-metastatic rhabdomyosarcomas in childhood and adolescence. Results of the second study of the International Society of Paediatric Oncology: MMT84.
Flamant F; Rodary C; Rey A; Praquin MT; Sommelet D; Quintana E; Theobald S; Brunat-Mentigny M; Otten J; Voûte PA; Habrand JL; Martelli H; Barrett A; Terrier-Lacombe MJ; Oberlin O
Eur J Cancer; 1998 Jun; 34(7):1050-62. PubMed ID: 9849454
[TBL] [Abstract][Full Text] [Related]
8. Randomized comparison of intensified six-drug versus standard three-drug chemotherapy for high-risk nonmetastatic rhabdomyosarcoma and other chemotherapy-sensitive childhood soft tissue sarcomas: long-term results from the International Society of Pediatric Oncology MMT95 study.
Oberlin O; Rey A; Sanchez de Toledo J; Martelli H; Jenney ME; Scopinaro M; Bergeron C; Merks JH; Bouvet N; Ellershaw C; Kelsey A; Spooner D; Stevens MC
J Clin Oncol; 2012 Jul; 30(20):2457-65. PubMed ID: 22665534
[TBL] [Abstract][Full Text] [Related]
9. [Paratesticular rhabdomyosarcoma].
Méndez Gallart R; Gómez Tellado M; Montero Sánchez M; Arnáiz Peña S; Vela Nieto D; País Piñeiro E
Actas Urol Esp; 1999 Jun; 23(6):549-52. PubMed ID: 10464968
[TBL] [Abstract][Full Text] [Related]
10. The role of retroperitoneal lymphadenectomy in localized paratesticular rhabdomyosarcoma.
Goldfarb B; Khoury AE; Greenberg ML; Churchill BM; Smith CR; McLorie GA
J Urol; 1994 Aug; 152(2 Pt 2):785-7. PubMed ID: 8022014
[TBL] [Abstract][Full Text] [Related]
11. Conservative approach in localised rhabdomyosarcoma of the bladder and prostate: results from International Society of Paediatric Oncology (SIOP) studies: malignant mesenchymal tumour (MMT) 84, 89 and 95.
Jenney M; Oberlin O; Audry G; Stevens MC; Rey A; Merks JH; Kelsey A; Gallego S; Haie-Meder C; Martelli H
Pediatr Blood Cancer; 2014 Feb; 61(2):217-22. PubMed ID: 23997024
[TBL] [Abstract][Full Text] [Related]
12. Paratesticular rhabdomyosarcoma: report from the Italian and German Cooperative Group.
Ferrari A; Bisogno G; Casanova M; Meazza C; Piva L; Cecchetto G; Zanetti I; Pilz T; Mattke A; Treuner J; Carli M
J Clin Oncol; 2002 Jan; 20(2):449-55. PubMed ID: 11786573
[TBL] [Abstract][Full Text] [Related]
13. Outcomes in paediatric metastatic rhabdomyosarcoma: results of The International Society of Paediatric Oncology (SIOP) study MMT-98.
McDowell HP; Foot AB; Ellershaw C; Machin D; Giraud C; Bergeron C
Eur J Cancer; 2010 Jun; 46(9):1588-95. PubMed ID: 20338746
[TBL] [Abstract][Full Text] [Related]
14. Analysis of prognostic factors in patients with nonmetastatic rhabdomyosarcoma treated on intergroup rhabdomyosarcoma studies III and IV: the Children's Oncology Group.
Meza JL; Anderson J; Pappo AS; Meyer WH;
J Clin Oncol; 2006 Aug; 24(24):3844-51. PubMed ID: 16921036
[TBL] [Abstract][Full Text] [Related]
15. Intergroup rhabdomyosarcoma study-IV: results for patients with nonmetastatic disease.
Crist WM; Anderson JR; Meza JL; Fryer C; Raney RB; Ruymann FB; Breneman J; Qualman SJ; Wiener E; Wharam M; Lobe T; Webber B; Maurer HM; Donaldson SS
J Clin Oncol; 2001 Jun; 19(12):3091-102. PubMed ID: 11408506
[TBL] [Abstract][Full Text] [Related]
16. [The treatment results in children with malignant mesenchymal tumors according to the protocols of the International Society of Pediatric Oncology (SIOP)].
López Pérez J; Melero Moreno C; Vivanco Martínez JL; Torres Valdivieso MJ; Cela de Julián E
An Esp Pediatr; 1996 Jun; 44(6):557-60. PubMed ID: 8849098
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis and treatment of lymph node metastases in pediatric rhabdomyosarcoma in the Netherlands: a retrospective analysis.
Terwisscha van Scheltinga CE; Spronk P; van Rosmalen J; Wijnen MH; Heij HA; van Baren R; Merks JH; van Noesel MM; Wijnen RM
J Pediatr Surg; 2014 Mar; 49(3):416-9. PubMed ID: 24650468
[TBL] [Abstract][Full Text] [Related]
18. [Pediatric rhabdomyosarcoma of the infratemporal fossa].
Rozan O; Janot F; Oberlin O; Schwaab G; Quintana E; Tran Ba Huy P; Georges B; Luboinski B
Ann Otolaryngol Chir Cervicofac; 2002 Sep; 119(4):195-201. PubMed ID: 12410115
[TBL] [Abstract][Full Text] [Related]
19. Ifosfamide and etoposide are superior to vincristine and melphalan for pediatric metastatic rhabdomyosarcoma when administered with irradiation and combination chemotherapy: a report from the Intergroup Rhabdomyosarcoma Study Group.
Breitfeld PP; Lyden E; Raney RB; Teot LA; Wharam M; Lobe T; Crist WM; Maurer HM; Donaldson SS; Ruymann FB
J Pediatr Hematol Oncol; 2001 May; 23(4):225-33. PubMed ID: 11846301
[TBL] [Abstract][Full Text] [Related]
20. Conservative treatment for girls with nonmetastatic rhabdomyosarcoma of the genital tract: A report from the Study Committee of the International Society of Pediatric Oncology.
Martelli H; Oberlin O; Rey A; Godzinski J; Spicer RD; Bouvet N; Haie-Meder C; Terrier-Lacombe MJ; Sanchez de Toledo J; Spooner D; Sommelet D; Flamant F; Stevens MC
J Clin Oncol; 1999 Jul; 17(7):2117-22. PubMed ID: 10561266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
